US Stock MarketDetailed Quotes
GHRS GH Research
- 11.190
- +0.200+1.82%
Close Apr 18 16:00 ET
582.19MMarket Cap-16455P/E (TTM)
11.310High10.780Low250.66KVolume11.130Open10.990Pre Close2.76MTurnover2.96%Turnover RatioLossP/E (Static)52.03MShares14.64052wk High2.66P/B94.79MFloat Cap5.05052wk Low--Dividend TTM8.47MShs Float30.430Historical High--Div YieldTTM4.82%Amplitude5.050Historical Low10.998Avg Price1Lot Size
About GH Research Company
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Sch?nharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.
Company Profile
SymbolGHRS
Company NameGH Research
Listing DateJun 25, 2021
Issue Price16.00
Founded2021
CEODr. Theis Terwey
MarketNASDAQ
Employees49
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressJoshua Dawson House,Dawson Street
CityDublin
ProvinceDublin
CountryIreland
Zip Code2
Phone353-1-437-8334
Websitehttp://www.ghres.com
Company Executives
- Name
- Position
- Salary
- Dr. Theis Terwey
- Chief Executive Officer
- --
- Aaron Cameron
- Chief Operating Officer
- --
- Dr. Velichka Valcheva, M.D.
- Chief Medical Officer
- --
- Julie Ryan
- Vice President, Finance
- --
- Florian Schonharting
- Chairman of the Board
- --
- Michael Forer
- Vice Chairman of the Board
- --
- Magnus Halle
- Managing Director, Ireland
- --
- Dr. Duncan Moore, PhD
- Independent Director
- --
- Dermot Hanley
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg